Showing results (521-530 of 616) with videos related to

Sort By:
Pageof 62
Science (New York, N.Y.)|March 21, 1998
Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositolS Joyce, A S Woods, J W Yewdell, et al.
Paediatrics & Child Health|February 24, 2025
Childhood dyslipidemia: Clinician management practices in the primary care settingKatherine N Tom, Alicia M Polack, Natasha D De Silva, et al.
Transplantation|October 9, 1999
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomideW J Waldman, D A Knight, N S Lurain, et al.
Stroke|November 1, 1982
Progress in cerebrovascular disease: local cerebral blood flow by xenon enhanced CTD Gur, S K Wolfson, H Yonas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 6, 2024
Neighborhood disadvantage, race, and clinical outcomes in neuromyelitis optica spectrum disorderJ R Abbatemarco, A Aboseif, C Swetlik, et al.
The Journal of Burn Care & Rehabilitation|July 1, 1986
Burn depth evaluation with fluorometry: is it really definitive?K S Black, C W Hewitt, D M Miller, et al.
The American Journal of the Medical Sciences|July 1, 1990
Oncogenes, malignant transformation, and modern medicineD M Miller, S Blume, M Borst, et al.
Biotechniques|May 25, 1999
Two-color GFP expression system for C. elegansD M Miller, N S Desai, D C Hardin, et al.
Gene Therapy|April 1, 1996
Efficient delivery of triplex forming oligonucleotides to tumor cells by adenovirus-polylysine complexesS W Ebbinghaus, N Vigneswaran, C R Miller, et al.
The Journal of Experimental Medicine|March 28, 1998
Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathwayD M Miller, B M Rahill, J M Boss, et al.
Pageof 62